Ocumension Therapeutics (HKG:1477)

Ocumension Therapeutics Revenue

In the year 2025, Ocumension Therapeutics had annual revenue of 804.35M CNY with 92.75% growth. Ocumension Therapeutics had revenue of 510.32M in the half year ending December 31, 2025, with 257.69% growth.

• Revenue: 804.35M CNY
• Revenue Growth: +92.75%
• P/S Ratio: 6.46
• Revenue / Employee: 1.46M CNY
• Employees: 552
• Market Cap: 5.78B HKD

Revenue Chart

* This company reports financials in CNY.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	804.35M	387.05M	92.75%
Dec 31, 2024	417.31M	170.94M	69.38%
Dec 31, 2023	246.37M	87.41M	54.99%
Dec 31, 2022	158.96M	102.81M	183.11%
Dec 31, 2021	56.15M	43.05M	328.73%

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

May 3, 2026

Data Sources Report a data error